RadNet Reports Record 14.8% Revenue Growth in Q4
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy RDNT?
Source: Newsfilter
- Significant Revenue Growth: RadNet reported total revenue of $547.7 million in Q4 2025, marking a 14.8% increase from $477.1 million in Q4 2024, reflecting strong demand in core markets and improved operational efficiencies.
- Record Adjusted EBITDA: The company achieved an adjusted EBITDA of $87.7 million in Q4, up 16.9% from $75.0 million in the same quarter last year, indicating substantial progress in cost control and operational efficiency, further enhancing profit margins.
- Strong Digital Health Performance: The Digital Health segment saw a 48.2% revenue increase to $27.9 million in Q4, with adjusted EBITDA rising 8.9% to $4.9 million, showcasing rapid expansion and technological innovation potential in this sector.
- Optimistic 2026 Outlook: RadNet anticipates 17%-19% revenue growth and 18%-22% adjusted EBITDA growth in the Imaging Center segment for 2026, indicating continued benefits from increasing market demand and the application of new technologies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RDNT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RDNT
Wall Street analysts forecast RDNT stock price to rise
6 Analyst Rating
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 72.090
Low
86.00
Averages
90.17
High
95.00
Current: 72.090
Low
86.00
Averages
90.17
High
95.00
About RDNT
RadNet, Inc. is a national provider of fixed-site diagnostic imaging services in the United States. The Company has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. It provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. It is also a provider of AI-powered breast health solutions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
RadNet Reports Record 14.8% Revenue Growth in Q4
- Significant Revenue Growth: RadNet reported total revenue of $547.7 million in Q4 2025, marking a 14.8% increase from $477.1 million in Q4 2024, reflecting strong demand in core markets and improved operational efficiencies.
- Record Adjusted EBITDA: The company achieved an adjusted EBITDA of $87.7 million in Q4, up 16.9% from $75.0 million in the same quarter last year, indicating substantial progress in cost control and operational efficiency, further enhancing profit margins.
- Strong Digital Health Performance: The Digital Health segment saw a 48.2% revenue increase to $27.9 million in Q4, with adjusted EBITDA rising 8.9% to $4.9 million, showcasing rapid expansion and technological innovation potential in this sector.
- Optimistic 2026 Outlook: RadNet anticipates 17%-19% revenue growth and 18%-22% adjusted EBITDA growth in the Imaging Center segment for 2026, indicating continued benefits from increasing market demand and the application of new technologies.
See More
RadNet Q4 Earnings Exceed Expectations
- Strong Performance: RadNet reported a Q4 Non-GAAP EPS of $0.23, beating expectations by $0.03, with revenue of $547.7 million reflecting a 14.8% year-over-year increase, surpassing estimates by $32.03 million, indicating robust market performance and profitability.
- Digital Health Growth: The Digital Health segment generated $27.9 million in revenue for Q4 2025, a 48.2% increase from Q4 2024, with adjusted EBITDA of $4.9 million, up 8.9%, showcasing the company's ongoing expansion and profitability in the digital health space.
- Imaging Center Outlook: RadNet's 2026 guidance for the Imaging Center segment projects total net revenue between $2.325 billion and $2.375 billion, with adjusted EBITDA expected to range from $335 million to $348 million, reflecting confidence in future growth and strategic planning.
- Capital Expenditure Plans: The company plans capital expenditures of $165 million to $175 million in 2026, with cash interest expenses projected at $45 million to $50 million, demonstrating RadNet's proactive approach to expansion and technology investments.
See More
RadNet to Host Q4 2025 Financial Results Conference Call on March 2, 2026
- Conference Call Announcement: RadNet will host a conference call on March 2, 2026, at 7:30 AM PT to discuss its Q4 2025 financial results, which is expected to attract investor interest and could impact stock performance.
- Participation Details: Investors can join the call by dialing 844-826-3035, with international callers using 412-317-5195, ensuring that global investors have access to the latest financial information, thereby enhancing transparency.
- Webcast and Replay Availability: The call will feature simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1753363&tp_key=503d78aa96, allowing investors who cannot attend live to access the information at their convenience, improving information accessibility.
- Company Overview: RadNet is a leading provider of freestanding diagnostic imaging services in the U.S., with over 12,000 employees and significant annual imaging revenue, highlighting its strong competitive position in the market.
See More
RadNet Acquires Northwest Radiology Network Assets, Expanding into Indiana
- Market Expansion: RadNet's acquisition of outpatient imaging assets from Northwest Radiology Network marks its entry into Indiana and the Midwest, adding six multimodality imaging centers and significantly enhancing its market coverage.
- Revenue Projection: The acquisition is projected to generate approximately $18 million in annual revenue for RadNet, further strengthening the company's financial performance and supporting its long-term growth strategy.
- Professional Resource Integration: The deal includes contracted services from 18 Northwest radiologists, enriching RadNet's professional team and enhancing its service capabilities in the local market.
- Strategic Positioning: This transaction signifies RadNet's strategic positioning in the Midwest, demonstrating the company's commitment to regional expansion through acquisitions to meet the growing demand for imaging services.
See More
RadNet Acquires Northwest Radiology Assets, Expands into Indiana
- Market Expansion: RadNet's acquisition of Northwest Radiology's outpatient imaging assets marks its entry into Indiana, enhancing its presence in the Midwest and is projected to add approximately $18 million in annual revenue, solidifying its leadership in the U.S. imaging services market.
- Technology Integration: This acquisition enables RadNet to leverage advanced AI technologies to enhance imaging workflows and clinical capabilities, thereby shifting Indiana's healthcare from reactive detection to proactive prevention, ultimately improving patient health outcomes.
- Commitment to Service Continuity: The 18 radiologists from Northwest Radiology will continue to provide professional services at the six newly acquired centers, ensuring continuity of care while maintaining strong relationships with local physicians, thereby enhancing community trust.
- Strategic Collaboration Prospects: The partnership between RadNet and Northwest Radiology will foster innovation in the imaging field, combining their strengths to enhance patient care quality and further drive standardization and excellence in healthcare services across Indiana.
See More
Rapid Growth in Cardiac AI Diagnostics Market
- Market Surge: The global medical imaging market reached $45.5 billion in 2026, indicating a significant shift towards AI-native precision, particularly due to the rising demand for heart monitoring in cancer treatments.
- Rise of Cardiac AI Diagnostics: The cardiac AI diagnostics sector hit $2.22 billion in 2026, driven by the urgent need for continuous imaging to monitor heart dysfunction, enhancing the company's competitive edge in the medical technology market.
- Strategic Partnership Enhances Value: Ventripoint's collaboration with Summit Sciences to develop ROI models illustrates how hospitals can achieve cost savings through technological improvements, further solidifying its market position in cardiac care.
- Executive Appointment Fuels Growth: The appointment of David Swetlow as CFO, with extensive experience in medical technology, is expected to accelerate market adoption and revenue growth, driving the execution of the company's commercial strategy.
See More
RadNet Reports Record 14.8% Revenue Growth in Q4
- Significant Revenue Growth: RadNet reported total revenue of $547.7 million in Q4 2025, marking a 14.8% increase from $477.1 million in Q4 2024, reflecting strong demand in core markets and improved operational efficiencies.
- Record Adjusted EBITDA: The company achieved an adjusted EBITDA of $87.7 million in Q4, up 16.9% from $75.0 million in the same quarter last year, indicating substantial progress in cost control and operational efficiency, further enhancing profit margins.
- Strong Digital Health Performance: The Digital Health segment saw a 48.2% revenue increase to $27.9 million in Q4, with adjusted EBITDA rising 8.9% to $4.9 million, showcasing rapid expansion and technological innovation potential in this sector.
- Optimistic 2026 Outlook: RadNet anticipates 17%-19% revenue growth and 18%-22% adjusted EBITDA growth in the Imaging Center segment for 2026, indicating continued benefits from increasing market demand and the application of new technologies.
See More
RadNet Q4 Earnings Exceed Expectations
- Strong Performance: RadNet reported a Q4 Non-GAAP EPS of $0.23, beating expectations by $0.03, with revenue of $547.7 million reflecting a 14.8% year-over-year increase, surpassing estimates by $32.03 million, indicating robust market performance and profitability.
- Digital Health Growth: The Digital Health segment generated $27.9 million in revenue for Q4 2025, a 48.2% increase from Q4 2024, with adjusted EBITDA of $4.9 million, up 8.9%, showcasing the company's ongoing expansion and profitability in the digital health space.
- Imaging Center Outlook: RadNet's 2026 guidance for the Imaging Center segment projects total net revenue between $2.325 billion and $2.375 billion, with adjusted EBITDA expected to range from $335 million to $348 million, reflecting confidence in future growth and strategic planning.
- Capital Expenditure Plans: The company plans capital expenditures of $165 million to $175 million in 2026, with cash interest expenses projected at $45 million to $50 million, demonstrating RadNet's proactive approach to expansion and technology investments.
See More
RadNet to Host Q4 2025 Financial Results Conference Call on March 2, 2026
- Conference Call Announcement: RadNet will host a conference call on March 2, 2026, at 7:30 AM PT to discuss its Q4 2025 financial results, which is expected to attract investor interest and could impact stock performance.
- Participation Details: Investors can join the call by dialing 844-826-3035, with international callers using 412-317-5195, ensuring that global investors have access to the latest financial information, thereby enhancing transparency.
- Webcast and Replay Availability: The call will feature simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1753363&tp_key=503d78aa96, allowing investors who cannot attend live to access the information at their convenience, improving information accessibility.
- Company Overview: RadNet is a leading provider of freestanding diagnostic imaging services in the U.S., with over 12,000 employees and significant annual imaging revenue, highlighting its strong competitive position in the market.
See More
RadNet Acquires Northwest Radiology Network Assets, Expanding into Indiana
- Market Expansion: RadNet's acquisition of outpatient imaging assets from Northwest Radiology Network marks its entry into Indiana and the Midwest, adding six multimodality imaging centers and significantly enhancing its market coverage.
- Revenue Projection: The acquisition is projected to generate approximately $18 million in annual revenue for RadNet, further strengthening the company's financial performance and supporting its long-term growth strategy.
- Professional Resource Integration: The deal includes contracted services from 18 Northwest radiologists, enriching RadNet's professional team and enhancing its service capabilities in the local market.
- Strategic Positioning: This transaction signifies RadNet's strategic positioning in the Midwest, demonstrating the company's commitment to regional expansion through acquisitions to meet the growing demand for imaging services.
See More
RadNet Acquires Northwest Radiology Assets, Expands into Indiana
- Market Expansion: RadNet's acquisition of Northwest Radiology's outpatient imaging assets marks its entry into Indiana, enhancing its presence in the Midwest and is projected to add approximately $18 million in annual revenue, solidifying its leadership in the U.S. imaging services market.
- Technology Integration: This acquisition enables RadNet to leverage advanced AI technologies to enhance imaging workflows and clinical capabilities, thereby shifting Indiana's healthcare from reactive detection to proactive prevention, ultimately improving patient health outcomes.
- Commitment to Service Continuity: The 18 radiologists from Northwest Radiology will continue to provide professional services at the six newly acquired centers, ensuring continuity of care while maintaining strong relationships with local physicians, thereby enhancing community trust.
- Strategic Collaboration Prospects: The partnership between RadNet and Northwest Radiology will foster innovation in the imaging field, combining their strengths to enhance patient care quality and further drive standardization and excellence in healthcare services across Indiana.
See More
Rapid Growth in Cardiac AI Diagnostics Market
- Market Surge: The global medical imaging market reached $45.5 billion in 2026, indicating a significant shift towards AI-native precision, particularly due to the rising demand for heart monitoring in cancer treatments.
- Rise of Cardiac AI Diagnostics: The cardiac AI diagnostics sector hit $2.22 billion in 2026, driven by the urgent need for continuous imaging to monitor heart dysfunction, enhancing the company's competitive edge in the medical technology market.
- Strategic Partnership Enhances Value: Ventripoint's collaboration with Summit Sciences to develop ROI models illustrates how hospitals can achieve cost savings through technological improvements, further solidifying its market position in cardiac care.
- Executive Appointment Fuels Growth: The appointment of David Swetlow as CFO, with extensive experience in medical technology, is expected to accelerate market adoption and revenue growth, driving the execution of the company's commercial strategy.
See More
